Both in Pharmaceuticals
Galectin Therapeutics vs Contineum Therapeutics
Over the past year GALT returned −34.5% and CTNM returned −10.9%; their daily moves had a correlation of 0.19.
GALT −34.5% CTNM −10.9%Growth of $1, one year, split-adjusted
| Metric | GALT | CTNM |
|---|---|---|
| Price | $3.32 | $9.39 |
| Market cap | $334.8M | $353.3M |
| Today | −5.68% | +0.64% |
| 1 month | −11.7% | −27.7% |
| 6 months | +46.3% | −28.9% |
| Year to date | −20.2% | −17.8% |
| 1 year | −35.0% | −13.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | -$19.8M | $236.6M |
| Dividend yield | — | — |
| Volatility (60d) | 65.6% | 117.5% |
| Short % of float | 13.7% | 13.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).